MetaADEDB 2.0 @ LMMD
Gadolinium
(UIWYJDYFSGRHKR-UHFFFAOYSA-N)
Structure
SMILES
[Gd]
Type(s)
Approved; Investigational
Molecular Formula:
Gd
Molecular Weight:
157.250
Log P:
0.0000
Hydrogen Bond Acceptor:
0
Hydrogen Bond Donor:
0
TPSA:
0
CAS Number(s):
7440-54-2
Synonym(s)
1.
Gadolinium
External Link(s)
MeSHD005682
PubChem Compound23982
ChEBI37294
33375
DrugBankDB12091
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1NauseaFAERS: 23
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
2ArthralgiaFAERS: 22
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
3Nephrogenic Fibrosing DermopathyFAERS: 22

View details

CTD
OFFSIDES
US FAERS
4PruritusFAERS: 20SIDER
US FAERS
5HeadacheFAERS: 17
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
6Nephrogenic Systemic FibrosisFAERS: 17
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
7FatigueFAERS: 15SIDER
US FAERS
8Gadolinium deposition diseaseFAERS: 14US FAERS
9Burning sensationFAERS: 13SIDER
US FAERS
10PainFAERS: 12
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
11Visual ImpairmentFAERS: 12SIDER
US FAERS
12Contrast media reactionFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
13Bone painFAERS: 10US FAERS
14DizzinessFAERS: 10
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
15MalaiseFAERS: 10SIDER
US FAERS
16VomitingFAERS: 10
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
17AstheniaFAERS: 9OFFSIDES
SIDER
US FAERS
18Feeling abnormalFAERS: 9SIDER
US FAERS
19TremorFAERS: 9SIDER
US FAERS
20DysgeusiaFAERS: 8
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
21MyalgiaFAERS: 8SIDER
US FAERS
22Musculoskeletal stiffnessFAERS: 7SIDER
US FAERS
23UrticariaFAERS: 7
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
24AlopeciaFAERS: 6OFFSIDES
US FAERS
25AnxietyFAERS: 6SIDER
US FAERS
26Contrast media depositionFAERS: 6US FAERS
27DyspepsiaFAERS: 6SIDER
US FAERS
28Eye irritationFAERS: 6US FAERS
29Feeling ColdFAERS: 6SIDER
US FAERS
30FormicationFAERS: 6US FAERS
31Joint stiffnessFAERS: 6US FAERS
32ArthropathyFAERS: 5US FAERS
33Chest PainFAERS: 5OFFSIDES
SIDER
US FAERS
34Chest discomfortFAERS: 5US FAERS
35ErythemaFAERS: 5SIDER
US FAERS
36Injection site painFAERS: 5
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
37Mental impairmentFAERS: 5US FAERS
38Skin hypertrophyFAERS: 5US FAERS
39TinnitusFAERS: 5SIDER
US FAERS
40AbasiaFAERS: 4OFFSIDES
US FAERS
41Abdominal PainFAERS: 4SIDER
US FAERS
42Back PainFAERS: 4SIDER
US FAERS
43Contrast media allergyFAERS: 4US FAERS
44Eye painFAERS: 4US FAERS
45HypersensitivityFAERS: 4SIDER
US FAERS
46Memory impairmentFAERS: 4US FAERS
47PalpitationsFAERS: 4SIDER
US FAERS
48Skin lesionFAERS: 4US FAERS
49SwellingFAERS: 4SIDER
US FAERS
50Toxicity to various agentsFAERS: 4US FAERS
51Anaphylactic shockFAERS: 3SIDER
US FAERS
52DehydrationFAERS: 3US FAERS
53Depressed Level of ConsciousnessFAERS: 3US FAERS
54DysuriaFAERS: 3SIDER
US FAERS
55Ear discomfortFAERS: 3US FAERS
56Nontherapeutic agent urine positiveFAERS: 3US FAERS
57Peripheral swellingFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
58SomnolenceFAERS: 3SIDER
US FAERS
59TachycardiaFAERS: 3SIDER
US FAERS
60Wheelchair userFAERS: 3OFFSIDES
US FAERS
61AmnesiaFAERS: 2US FAERS
62Anaphylactoid ReactionFAERS: 2SIDER
US FAERS
63AsthmaFAERS: 2OFFSIDES
SIDER
US FAERS
64BedriddenFAERS: 2OFFSIDES
US FAERS
65Cardiac ArrestFAERS: 2SIDER
US FAERS
66Chemical burn of skinFAERS: 2US FAERS
67Cold sweatFAERS: 2US FAERS
68Documented hypersensitivity to administered drugFAERS: 2US FAERS
69Essential TremorFAERS: 2US FAERS
70Flank PainFAERS: 2OFFSIDES
US FAERS
71FlushingFAERS: 2SIDER
US FAERS
72Head discomfortFAERS: 2US FAERS
73HypotensionFAERS: 2SIDER
US FAERS
74Impaired driving abilityFAERS: 2US FAERS
75Impaired work abilityFAERS: 2US FAERS
76InflammationFAERS: 2SIDER
US FAERS
77Medication ErrorFAERS: 2US FAERS
78NeuralgiaFAERS: 2US FAERS
79Pain of skinFAERS: 2US FAERS
80PallorFAERS: 2SIDER
US FAERS
81Peritoneal DialysisFAERS: 2OFFSIDES
US FAERS
82Phantom painFAERS: 2US FAERS
83Post procedural complicationFAERS: 2OFFSIDES
US FAERS
84Rash erythematousFAERS: 2US FAERS
85Respiratory distressFAERS: 2SIDER
US FAERS
86RestlessnessFAERS: 2US FAERS
87SepsisFAERS: 2US FAERS
88Skin UlcerFAERS: 2US FAERS
89StomatitisFAERS: 2US FAERS
90Temperature intoleranceFAERS: 2OFFSIDES
US FAERS
91ThirstFAERS: 2SIDER
US FAERS
92Throat irritationFAERS: 2US FAERS
93ThrombosisFAERS: 2US FAERS
94VertigoFAERS: 2SIDER
US FAERS
95Weight decreasedFAERS: 2US FAERS
96WheezingFAERS: 2SIDER
US FAERS
97fibromaFAERS: 2US FAERS
98Abdominal discomfortFAERS: 1US FAERS
99Activities of daily living impairedFAERS: 1OFFSIDES
US FAERS
100Acute kidney injuryFAERS: 118472687CTD
SIDER
US FAERS
101Adverse eventFAERS: 1US FAERS
102Altered state of consciousnessFAERS: 1US FAERS
103AneurysmFAERS: 1US FAERS
104Anorectal discomfortFAERS: 1US FAERS
105ArthritisFAERS: 1OFFSIDES
US FAERS
106Atrial FibrillationFAERS: 1US FAERS
107Autonomic nervous system imbalanceFAERS: 1US FAERS
108Bladder painFAERS: 1US FAERS
109Blood arsenic increasedFAERS: 1OFFSIDES
US FAERS
110Blood count abnormalFAERS: 1US FAERS
111Blood creatinine increasedFAERS: 1SIDER
US FAERS
112Blood iron increasedFAERS: 1US FAERS
113Blood urea increasedFAERS: 1US FAERS
114Body temperature fluctuationFAERS: 1US FAERS
115BradycardiaFAERS: 1SIDER
US FAERS
116BronchitisFAERS: 1US FAERS
117Carpal Tunnel SyndromeFAERS: 1US FAERS
118Chemical injuryFAERS: 1US FAERS
119ChillsFAERS: 1SIDER
US FAERS
120ConstipationFAERS: 1SIDER
US FAERS
121CyanosisFAERS: 1SIDER
US FAERS
122CystitisFAERS: 1US FAERS
123DeformityFAERS: 1US FAERS
124Dental cariesFAERS: 1US FAERS
125Depressed moodFAERS: 1US FAERS
126Diabetic end stage renal diseaseFAERS: 1US FAERS
127DiplegiaFAERS: 1US FAERS
128DiscomfortFAERS: 1SIDER
US FAERS
129DisorientationFAERS: 1US FAERS
130Drug screen positiveFAERS: 1US FAERS
131Dry skinFAERS: 1SIDER
US FAERS
132Electromechanical dissociationFAERS: 1OFFSIDES
US FAERS
133EpistaxisFAERS: 1SIDER
US FAERS
134ExcoriationFAERS: 1OFFSIDES
US FAERS
135Facial ParesisFAERS: 1US FAERS
136Feeling of body temperature changeFAERS: 1US FAERS
137FibromyalgiaFAERS: 1US FAERS
138FlatulenceFAERS: 1SIDER
US FAERS
139Gastrointestinal PainFAERS: 1SIDER
US FAERS
140General physical health deteriorationFAERS: 1US FAERS
141Hair metal test abnormalFAERS: 1US FAERS
142Histamine level increasedFAERS: 1OFFSIDES
US FAERS
143HungerFAERS: 1US FAERS
144HyperkeratosisFAERS: 1US FAERS
145HyperventilationFAERS: 1US FAERS
146HypophagiaFAERS: 1US FAERS
147HypothyroidismFAERS: 1US FAERS
148Immediate post-injection reactionFAERS: 1US FAERS
149IncontinenceFAERS: 1US FAERS
150Infusion site painFAERS: 1US FAERS
151Injection site cellulitisFAERS: 1US FAERS
152Injection site joint movement impairmentFAERS: 1US FAERS
153Injection site massFAERS: 1US FAERS
154Injection site pruritusFAERS: 1US FAERS
155Injection site warmthFAERS: 1US FAERS
156Intra-abdominal pressure increasedFAERS: 1US FAERS
157Irritable Bowel SyndromeFAERS: 1US FAERS
158Joint Range of Motion DecreasedFAERS: 1US FAERS
159Joint swellingFAERS: 1US FAERS
160Limb discomfortFAERS: 1US FAERS
161Limb injuryFAERS: 1US FAERS
162Lip swellingFAERS: 1SIDER
US FAERS
163Loss of proprioceptionFAERS: 1US FAERS
164LymphadenopathyFAERS: 1US FAERS
165MeningiomaFAERS: 1US FAERS
166MeningitisFAERS: 1US FAERS
167Mental FatigueFAERS: 1US FAERS
168Multiple Chemical SensitivityFAERS: 1US FAERS
169Multiple SclerosisFAERS: 1US FAERS
170Muscle RigidityFAERS: 1US FAERS
171Muscle SpasticityFAERS: 1US FAERS
172Muscle tightnessFAERS: 1US FAERS
173Musculoskeletal chest painFAERS: 1US FAERS
174MydriasisFAERS: 1US FAERS
175MyoclonusFAERS: 1US FAERS
176NephrosclerosisFAERS: 1US FAERS
177Nerve injuryFAERS: 1US FAERS
178Night sweatsFAERS: 1US FAERS
179NystagmusFAERS: 1US FAERS
180OnychoclasisFAERS: 1US FAERS
181Open woundFAERS: 1US FAERS
182Oropharyngeal painFAERS: 1OFFSIDES
US FAERS
183OsteomyelitisFAERS: 1OFFSIDES
US FAERS
184POEMS SyndromeFAERS: 1US FAERS
185PresyncopeFAERS: 1SIDER
US FAERS
186Procedural complicationFAERS: 1US FAERS
187Product quality issueFAERS: 1US FAERS
188ProteinuriaFAERS: 1US FAERS
189Radiation injuryFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
190Radiation skin injuryFAERS: 1US FAERS
191Reaction to azo-dyesFAERS: 1US FAERS
192Renal cystFAERS: 1US FAERS
193Renal painFAERS: 1US FAERS
194Renal tubular necrosisFAERS: 1US FAERS
195Restless Legs SyndromeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
196RetchingFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
197SclerodermaFAERS: 1OFFSIDES
US FAERS
198Sinus TachycardiaFAERS: 1US FAERS
199Skin discomfortFAERS: 1US FAERS
200Skin reactionFAERS: 1US FAERS
201Skin texture abnormalFAERS: 1US FAERS
202SneezingFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
203Splenic cystFAERS: 1US FAERS
204SplinterFAERS: 1US FAERS
205StressFAERS: 1US FAERS
206SyncopeFAERS: 1SIDER
US FAERS
207TenosynovitisFAERS: 1US FAERS
208Thermal burnFAERS: 1US FAERS
209TorticollisFAERS: 1US FAERS
210Tricuspid Valve StenosisFAERS: 1US FAERS
211TrismusFAERS: 1US FAERS
212Unevaluable eventFAERS: 1US FAERS
213Urinary IncontinenceFAERS: 1US FAERS
214Urine output increasedFAERS: 1US FAERS
215Venous InjuryFAERS: 1US FAERS
216Ventricular FibrillationFAERS: 1US FAERS
217Vulvovaginal burning sensationFAERS: 1US FAERS
218Waist circumference increasedFAERS: 1US FAERS
219Walking aid userFAERS: 1US FAERS
220Wrong technique in drug usage processFAERS: 1US FAERS
221jaundiceFAERS: 1US FAERS
222Abnormal cervical smearOFFSIDES
223Abnormal visionOFFSIDES
224AcanthosisOFFSIDES
225Acute Coronary SyndromeOFFSIDES
226Acute respiratory failureOFFSIDES
227Acute sinusitisOFFSIDES
228AgitationSIDER
229AkathisiaSIDER
230AmblyopiaSIDER
231AngioedemaSIDER
232AnhidrosisOFFSIDES
233AnorexiaSIDER
234Antiphospholipid SyndromeOFFSIDES
235Application site reactionSIDER
236ArteriosclerosisOFFSIDES
237Arteriovenous fistula occlusionOFFSIDES
238Arteriovenous fistula site complicationOFFSIDES
239Arteriovenous fistula thrombosisOFFSIDES
240Arteriovenous graft thrombosisOFFSIDES
241AtelectasisOFFSIDES
242Atrial thrombosisOFFSIDES
243Avascular necrosisOFFSIDES
244Basal cell carcinomaOFFSIDES
245BasophiliaSIDER
246Blood and lymphatic system disordersSIDER
247Blood glucose decreasedOFFSIDES
248Blood heavy metal increasedCanada Vigilance: 1Canada Vigilance
249Bone density increasedOFFSIDES
250BronchospasmSIDER
251CalciphylaxisOFFSIDES
252CataractOFFSIDES
253CellulitisOFFSIDES
254Choking sensationOFFSIDES
255Circumstance or information capable of leading to medication errorOFFSIDES
256CoccidioidomycosisOFFSIDES
257Colon adenomaOFFSIDES
258Congenital tricuspid valve incompetenceOFFSIDES
259Conjunctival depositOFFSIDES
260ConjunctivitisSIDER
261Cramps of lower extremitiesSIDER
262Creatinine increasedSIDER
263DermatitisSIDER
264Device related infectionOFFSIDES
265Diabetic ulcerOFFSIDES
266DiplopiaSIDER
267DiverticulumOFFSIDES
268DuodenitisOFFSIDES
269EmbolismOFFSIDES
270EncephalomalaciaOFFSIDES
271EndophthalmitisSIDER
272EntropionOFFSIDES
273EructationSIDER
274Erythema MultiformeSIDER
275Eustachian tube disorderOFFSIDES
276ExtravasationSIDER
277Femoral artery occlusionOFFSIDES
278Fluid overloadOFFSIDES
279FrustrationOFFSIDES
280GangreneOFFSIDES
281GastroenteritisOFFSIDES
282GliomaSIDER
283GoiterOFFSIDES
284GranulocytosisOFFSIDES
285Hay feverOFFSIDES
286HemiparesisOFFSIDES
287Heparin-induced thrombocytopeniaOFFSIDES
288Hepatitis COFFSIDES
289HyperacusisSIDER
290HyperparathyroidismOFFSIDES
291Hypertrophic CardiomyopathyOFFSIDES
292IleitisOFFSIDES
293Incisional herniaOFFSIDES
294InfectionOFFSIDES
295Injection Site ReactionSIDER
296Injection site bruisingSIDER
297Injection site coldnessSIDER
298Injection site inflammationSIDER
299Intervertebral disc disorderOFFSIDES
300KeratopathyOFFSIDES
301Kidney Diseases

View details

CTD
302Kidney FailureOFFSIDES
303LaryngospasmSIDER
304Left Ventricular HypertrophyOFFSIDES
305Left atrial dilatationOFFSIDES
306Mental status changesOFFSIDES
307Metabolic acidosisOFFSIDES
308Musculoskeletal discomfortSIDER
309Neck PainSIDER
310Neck stiffnessSIDER
311NecrosisSIDER
312NervousnessSIDER
313No reaction on previous exposure to drugOFFSIDES
314Nuchal RigiditySIDER
315NumbnessSIDER
316Occult blood positiveOFFSIDES
317OliguriaSIDER
318Oropharyngeal discomfortSIDER
319Oropharyngeal swellingSIDER
320Pelvic PainSIDER
321Pericardial effusionOFFSIDES
322PericarditisOFFSIDES
323PeritonitisOFFSIDES
324PharyngitisSIDER
325PneumothoraxOFFSIDES
326Poor quality sleepOFFSIDES
327Procedural hypotensionOFFSIDES
328Quality of life decreasedOFFSIDES
329Renal Insufficiency19537311CTD
330Respiratory arrestCanada Vigilance: 1Canada Vigilance
SIDER
331Retinal vascular thrombosisOFFSIDES
332RhinitisSIDER
333ScabCanada Vigilance: 1Canada Vigilance
334ShockSIDER
335SinusitisOFFSIDES
SIDER
336Splenic InfarctionOFFSIDES
337Staphylococcal osteomyelitisOFFSIDES
338TensionSIDER
339ThrombocytopeniaSIDER
340ThrombophlebitisSIDER
341Thrombosis in deviceOFFSIDES
342Trigeminal palsyOFFSIDES
343Vascular stenosisOFFSIDES
344VasospasmSIDER
345Venipuncture site bruiseSIDER
346Vessel puncture site bruiseSIDER
347Visual disturbanceSIDER
348Wound ComplicationCanada Vigilance: 1Canada Vigilance
349Wound infection staphylococcalOFFSIDES
350nervous system disorderSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.